Home › Multiple Myeloma › New Hampshire
Multiple Myeloma clinical trials in New Hampshire
4 studies for Multiple Myeloma are looking for participants at sites in New Hampshire.
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Dartmouth Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05552222TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NH Oncology - Hematology, PA, Concord
- Solinsky Center for Cancer Care, Manchester
- New England Cancer Specialist, Portsmouth
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07280013Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Exeter Hospital, Exeter
RecruitingPhase 3
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.